INTRODUCTION
The prevalence of myopia (nearsightedness) has increased dramatically in developed countries in recent decades [Bar Dayan, et al. 2005; Vitale, et al. 2009] . Myopia is a complex, multifactorial disease with increasing public health burden due to a strong rise worldwide. In particular high myopia is associated with blinding complications such as myopic macular degeneration, glaucoma and retinal detachment [Curtin and Karlin 1971; McBrien and Gentle 2003; Saw 2006] . High myopia mostly has its onset in early childhood before age 10 years [Fledelius 2000 ].
The eye's dimensions alter markedly during the peak development phase between birth and the late teenage years, ultimately exerting very strong effects on final refractive error (RE) in later adult life. A complex process called emmetropisation aims to coordinate ocular development, bringing light into clear focus on the retina. Early life myopia is characteristically associated with excessive axial length (AL) increase. This results in a mismatch of the optical effects of the various refractive components of the eye, resulting in a focal point in front of the retina. Such a mismatch can be described by the ratio of AL to corneal radius (CR), AL/CR ratio, which has a high correlation with RE [Hashemi, et al. 2013; Ip, et al. 2007 ] and is independent of cycloplegia which may vary between studies.
Various studies have examined the heritability of myopia showing increased risk for firstdegree relatives of affected individuals [Farbrother, et al. 2004; Guggenheim, et al. 2000 ] and twins [Sanfilippo, et al. 2010; Young, et al. 2007] . Numerous genetic loci that cause familial high myopia (MYP1-18) have been discovered using linkage analysis [Baird, et al. 2010 ]. More recently, genome wide association studies (GWAS) in large cohorts have been performed to identify further determinants for REs in the general population. The first single nucleotide polymorphisms (SNPs) identified were near GJD2 and RASGRF1 . Later many more loci were found in studies of large populations (CREAM; 23andMe) [Kiefer, et al. 2013; Verhoeven, et al. 2013 ] .
All previously published refractive error GWAS studies were performed in cohorts enrolling participants aged 25 years and older. We aimed to study the effect size of the 39 GWAS-identified genetic regions associated with refractive error to date, as a function of age.
METHODS

Study specific analysis
We included 18 cohorts from 8 different countries in Europe, Asia and Oceania, with a total of 5,490 children <10 years, 5,000 individuals of 10-25 years, and 16,274 adults, all with phenotypic and genome-wide genotypic data available. Age cut off points were based on prior knowledge regarding eye growth. The eye has the highest growth rate before the age of 10 years, and generally does not grow in axial length after age 25 years [Zadnik, et al. 2003 ].
Details on subject recruitment procedures can be found in the supplemental materials. Each study participant was genotyped with either an Affymetrix or Illumina SNP array (supplemental table I ). All studies were conducted according to the Declaration of Helsinki. The studies were approved by the local review boards. Written, informed consent for the collection and analysis of measurements of all study participants was obtained.
SNPs
A total of 39 SNPs were included in this analysis. The SNPs were selected based on their known association with RE and myopia in the GWAS carried out by CREAM [Verhoeven, et al. 2013 ] and 23andMe [Kiefer, et al. 2013] (supplementary table II ). An unweighted genetic risk score (GRS) was calculated for each participant by summing the dosage of risk alleles (scale 0-2) for all 39 SNPs. The risk score was normally distributed.
Ocular biometry
The ocular biometry measurements included AL and CR, and the AL/CR ratio was calculated.
Multiple measurements of AL and CR were taken of the right eye and left eye, were averaged to calculate a mean AL and CR for each eye. The average AL of both eyes was divided by the average CR of both eyes to calculate the AL/CR ratio. Details of the phenotypic assessment protocols/instruments used in each study can be found in the supplemental material.
Meta-analysis
All studies performed linear regression models with each SNP or the GRS as determinants, and the AL/CR ratio as outcome. Analyses were adjusted for the potentially confounding effects of age and gender, and additionally -to account for ancestry differences within the sample -for principal components where applicable. A meta-analysis was performed to estimate the beta effects using an inversed variance weighted fixed effect model with METAL [Willer, et al. 2010 ].
Meta-analyses were performed in each age stratum separately, and in combined strata of all participants <25 years. Several children measured in TEST (Twins Eye Study Tasmania) and GTES (Guangzhou Twin Eye Study) had follow up measurements at an older age; therefore, only data from the oldest age were used in the combined analysis. In the Asian studies the following SNPs were excluded due to low minor allele frequency (MAF) <0.05 in the Chinese population: rs17428076, rs1656404, rs14165, rs13091182, rs12205363, rs11145465, rs10882165, and rs17183295.
Pathway analysis
Loci with significant effects (P <0.05) were further explored to identify differences in effect of early-onset genes (significant loci identified in groups <10 years, 10-25 years or the combined analysis) and late-onset genes (adult subjects). Data were analysed through the use of QIAGEN's Ingenuity®.
Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) and the online software tool Database for Annotation, Visualization and Integrated Discovery (DAVID) [Huang da, et al. 2009a; Huang da, et al. 2009b] .
RESULTS
Our study sample of children <10 years comprised 5,490 participants derived from 5 studies; one of European ancestry (TEST), three of Asian ancestry (SCORM, STARS, and Guangzhou Twins), and one of mixed European, African, and Asian ancestry (Generation R). Our sample of individuals aged 10-25 years included 5,000 participants derived from 6 studies; 4 of European ancestry (TEST, ALSPAC, BATS and RAINE) , and 2 of Asian (STARS, Guangzhou Twins) ancestry. Our sample of adults >25 years compromised 16,274 participants derived from 10 studies; 9 of European ancestry (Croatia Split, -Kurcula and -Vis study, Gothenburg Health Study, EPIC-Norfolk and the Rotterdam Study I-III), and one Asian study (Nagahama). General characteristics per study are shown in Table I .
Genetic risk score
The genetic risk score was associated with a higher AL/CR ratio even in children aged <10 years (table II) , and this association increased in magnitude with older age. Specifically, AL/CR increased with each age category from β 0.0019 (SD 0.0003) per risk allele in children <10 years, to 0.0033 (SD 0.0004) in participants aged 10-25 years, to 0.0051 (SD 0.0003) in adults (figure I). Only the adult group showed evidence for heterogeneity (heterogeneity P-value 0.0005) between studies, therefore, meta-analyses for this age category were also performed using the random effect model (β 0.0048; SD 0.0007; supplementary table IV). The variance explained by the genetic risk score increased from 0.7% in the children aged 6 from the Generation R study, to 3.7% for the adult participants in the RS I-III (Fig II) .
Genetic loci
In children <10 years, 9/39 loci were significant at P <0.05, and 3/39 were significant after correction for multiple-testing for 39 SNPs (P <0.00128). The 3 loci significant after Bonferroni correction were in the vicinity of the genes GJD2, ZIC2 and CHRNG. The 2 nominally-significant loci with the greatest effect size (beta) were close to the CHRNG and PRSS56 genes. The other 5 loci were near KCNQ5, SHISA6, KCNMA1, BMP2 and BICC1. Interestingly, the SNP at the BMP2 locus had a reversed effect from that observed in adult samples, i.e., the risk allele was associated with a lower AL/CR ratio. In individuals aged 10 -25 years, 10/39 loci showed nominally significant association with AL/CR ratio, of which 5 survived Bonferroni correction (BMP2, TOX, KCNQ5, A2BP1 and CACNA1D). Five of the 10 SNPs above were already nominal significantly associated with AL/CR ratio in children <10 years (GJD2, BICC1, ZIC2, BMP2 and PRSS56); of the remaining nominally-significant loci, the variant with the greatest effect in 10-25 year-olds was the SNP at the LAMA2 locus. One variant differed significantly in effect between children <10 years and those aged 10-25 years. This was the SNP at the BMP2 locus which, as mentioned above, showed an opposite effect to that expected in children aged <10 years ( Figure III) . One of the loci (TOX) showed evidence for heterogeneity (supplementary table III) in effect between study cohorts in the age category 10-25 years (Heterogeneity P = 0.001). With random effect model the effect of this SNP decreased to β 0.0062 (SE 0.0073; P 0.40)(supplementary table IV). In the combined analysis of all studies <25 years, BICC1 and PRSS56 reached Bonferroni adjusted significance; one additional locus (PDE11A) showed a nominally significant effect for AL/CR ratio. In adults, 31/39 loci showed a significant effect, of which 19/39 were Bonferroni significant. All loci, except for ZBTB38 (β -0.0004; SE 0.0019),
showed an association in the expected direction (i.e. risk allele associated with a higher AL/CR ratio). As in 10-25 years, one locus significant in adults showed evidence for heterogeneity (LOC100506035); with random effect model this locus lost statistical significance (supplementary table III 
Pathway analysis
Pathway analyses were performed to gain insight into the mechanisms for early versus lateonset eye growth and myopia development. We hypothesized that loci with at least a moderate (nominally significant P<0.05) effect in children and adolescents most likely had an early onset.
Hence, a locus was defined as early onset when nominally significant (P<0.05) in the group<10 years of age or the group 10-25 years and no evidence for heterogeneity (in Figure IV all loci above the green line). Loci nominally significant in the adult population without a significant effect in the group<10 years of age or the group 10-25 years were grouped as late onset genes (in Figure IV all loci below the green line). We utilized two types of pathway analysis software.
Ingenuity Pathway Analysis (IPA)
IPA is a web-based software to analyse and integrate the identified SNPs based on biological functions. Analysis were performed in two separate analysis, one analysis with genes with an early onset and one analysis with late onset genes. We used the program's diseases and disorder table to identify associated diseases. Genes with an early onset in the age groups <25 years were enriched in pathways of auditory disease, organismal injury and abnormalities, and gastrointestinal disease (at FDR <5%). The genes that were significantly associated in adults predisposed to connective tissue disorders, developmental disorder (e.g. microphthalmia; with the genes BMP4 and SIX6), and also gastrointestinal disease (supplementary table V).
Database for Annotation, Visualization and Integrated Discovery (DAVID)
The software program DAVID is an online knowledge database to identify overlapping functions of genes. We performed the analyses separately for early and late onset genes. Using the categories defined above, early-onset genes were significantly more than expected annotated to ion channels and ion transport. The genes annotated to these categories were CACNA1D, CHRNG, GJD2, KCNMA1 and KCNQ5. Late onset genes appeared to be significantly more related to neuron differentiation and visual perception. The genes involved in these categories were RORB, SIX6, RASGRF1, CHD7, RGR, RDH5 and GRIA4. (supplementary table VI) .
DISCUSSION:
This study identifies the age span during which the known GWAS-identified loci for refractive error have their greatest effect. The current meta-analysis suggests that specific loci had their greatest effect in young children (CHRNG, ZIC2, KCNMA1) , while others reached the greatest effect during early teenage years (BMP2, CACNA1D, A2BP1). However, most appeared to have a gradual effect during the entire age span of myopia development (LAMA2, LRRC4C, DLX1,
RDH5, GRIA4, RGR, SIX6).
Strengths of this study were the large sample size, the comparison across 3 distinct age categories, and the precision in measurements of ocular biometry. A drawback was the lack of complete cycloplegic refraction in children in several studies, which jeopardized valid measurements of RE in this age category. Thus, we used AL/CR ratio as an indicator of RE to avoid heterogeneity in the outcome. This ratio has a high correlation with RE [Hashemi, et al. 2013; Ip, et al. 2007 ] and was available from all studies in the consortium. Another limitation was the lack of power to detect statistically significant differences between the age groups for most genes. A pooled analysis would have increased statistical power, but raw data from individual participants were not available. Ideally, a study using longitudinal data of the same children over different age periods would have the best study design for the current analysis.
Little has been reported on the development and progression of myopia as a function of age; however, a number of studies investigated the relationship between development of ocular biometry related to age. Until the age of 25 years, corneal curvature, the crystalline lens, and axial length all evolve with age, and thereby influence refractive error. The cornea increases in radius until preschool age leading to flattening of the corneal curvature and decrease in refractive power [Augusteyn, et al. 2012] ; the crystalline lens grows until 10 years of age, also reducing refractive power [Mutti, et al. 2012; Mutti, et al. 1998 ]. This decrease in refractive power is compensated by axial elongation which increases from 17 mm in newborns [Lim, et al. 2015 ] to 23.3 mm in 12-13 year olds [French, et al. 2012] . The average AL in emmetropic adults is 23.5 mm [Fotedar, et al. 2010; Gordon and Donzis 1985] . The highest growth rate of AL occurs in the first years of life and relates to emmetropisation; the growth rate after early teens is more gradual but mainly relates to myopisation [Gordon and Donzis 1985] . The exact age at which eye growth stops is not known; generally this occurs before age 20 years, but increase in AL has been described up to the age of 25 years in university students [Fledelius 2000; Midelfart, et al. 1992] .
One of the key detected GWAS-identified loci for refractive error is on chromosome 15 near the GJD2 gene, that encodes a gap junction protein known as CX36. This protein not only processes cone-to-cone and cone-to-rod signals [Lee, et al. 2003 ] but also directs signaling between other retinal cells [Feigenspan, et al. 2001; Hidaka, et al. 2004] . This cell-to-cell communication appears to be under regulation of light exposure and dopamine [Bloomfield and Volgyi 2009], two factors that have an established role in eye growth and myopia development.
Our data suggest that GJD2 has an early-onset, indicating that altered retinal cell signaling, perhaps via reduced light exposure and low dopamine levels, may be a first step in myopia development. As expected, some early-onset genes also had a reported role in eye development. Knockout of LAMA2, a gene encoding the large extracellular glycoprotein laminin-α2; causes growth retardation including smaller eyes with compressed cellular layers [Gupta, et al. 2012] . Mutations in the serine protease gene PRSS56 cause a severe decrease of AL leading to microphthalmia [Nair, et al. 2011] . Another developmental gene is ZIC2, an enhancer-binding factor required for embryonic stem cell specification [Luo, et al. 2015] . This gene may be important for development of retinal architecture, as it is known to be involved in differentiation and proliferation of retinal progenitor cells [Watabe, et al. 2011] , and development of retinal ganglion cell trajectories [Herrera, et al. 2003 ]. Strikingly, several other genes involved in eye development, such as SIX6, CDH7, and DLX1, did not show an early onset but were more significant after the age of 10 years. Other early-onset genes were ion channels such as KCNQ5, a potassium channel present in cone and rod photoreceptors [Zhang, et al. 2011] , and CACNA1D, a calcium channel present in photoreceptors [Xiao, et al. 2007] . CHRNG has as yet an unknown role in myopia development. It encodes the γ subunit of the embryonal acetylcholine receptor, which is widely expressed in the retina [Hruska, et al. 1978; Hutchins and Hollyfield 1985] , and is associated with multiple pterygium syndrome [Vogt, et al. 2012 ].
Several remarkable patterns of effect were notable. For instance, the lead SNPs at the BMP2, MYO1D, PTPRR, and BMP4 loci showed an opposite effect in children <10 years than in those who were older. This is not uncommon in biology, as such a trajectory has also been described for the FTO locus in relation to body mass index in children [Sovio, et al. 2011 ].
Interestingly, gene expression studies of BMP2 in chickens showed that mRNA of this gene in the retinal pigment epithelium is up-or down-regulated depending on the location of the image plane [Zhang, et al. 2012] . When the image was focused behind the retina, mRNA was downregulated and the vitreous chamber enlarged. This underscores a bidirectional role for BMP2 in modulation of eye growth.
Most genes had a late onset. BMP4 has a similar function to BMP2 as it is also responds to optical defocus with bidirectional regulation of eye growth [Zhang, et al. 2013] . SIX6 is a DNA-binding homeobox and has a SIX domain, which binds downstream effector molecules. It is known to influence eye size in zebrafish with knocked down SIX6 expression [Iglesias, et al. 2014] . Other genes play a less obvious role in myopiagenesis. MYO1D is involved in membrane trafficking in the recycling pathway and expressed in oligodendrites [Benesh, et al. 2012] .
RORB, a gene encoding a nuclear receptor-directing photoreceptor differentiation, is known to activate and generate S-opsin [Jia, et al. 2009; Srinivas, et al. 2006] . DLX1 belongs to the DLX family of homeobox transcription factors, and produces GABAergic interneurons during embryonic development.
In conclusion, our study suggests that only a small proportion of the currently known GWAS-identified loci for RE exert their full effect at a young age. Furthermore, some of the pathways previously-identified by GWAS meta-analyses [Verhoeven, et al. 2013 ] can now be separated into early-and late-onset pathways. For example, genes coding for ion channels typically had an early onset, while genes related to connective tissue and visual feedback mechanisms appeared to become more important at a later age. As the currently known genes play only a minor role in early-onset myopia, we question whether this type of myopia is caused by common variants in other genes, or whether rare variants with large effects determine earlyonset. Future research may shed more light on genes for early-onset myopia, and unravelling these genes will open up strategies for prevention of high myopia. Figure I . Association between genetic risk score and myopia in the three age groups Figure II . Association between non-weighted genetic risk score and AL/CR ratio in children and adults.
Figure III. Increased effect on AL/CR ratio with age for BMP2 gene. Figure IV . Distribution of effects on AL/CR ratio per myopia-related gene in three age groups
